Literature DB >> 10603523

Novel and Innovative Dosing Regimens in Thrombolytic Therapy for Acute Myocardial Infarction.

.   

Abstract

Entities:  

Year:  1995        PMID： 10603523     DOI： 10.1007/BF01062571

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  26 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.

Authors:  E M Ohman; R M Califf; E J Topol; R Candela; C Abbottsmith; S Ellis; K N Sigmon; D Kereiakes; B George; R Stack
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

3.  Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction.

Authors:  U Tebbe; P Tanswell; E Seifried; W Feuerer; K H Scholz; K S Herrmann
Journal:  Am J Cardiol       Date:  1989-09-01       Impact factor: 2.778

4.  Streptokinase in recent myocardial infarction: a controlled multicentre trial. European working party.

Authors: 
Journal:  Br Med J       Date:  1971-08-07

5.  Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.

Authors:  P Tanswell; U Tebbe; K L Neuhaus; L Gläsle-Schwarz; J Wojcik; E Seifried
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

6.  A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.

Authors:  J D Gemmill; K J Hogg; P D MacIntyre; N Booth; A P Rae; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1991-08

7.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors:  F Van de Werf; A E Arnold
Journal:  BMJ       Date:  1988-11-26

8.  Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies).

Authors:  A Vogt; R von Essen; U Tebbe; W Feuerer; K F Appel; W Niederer; K L Neuhaus
Journal:  Am J Cardiol       Date:  1994-07-01       Impact factor: 2.778

9.  Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.

Authors:  B Tranchesi; D F Chamone; C Cobbaert; F Van de Werf; P Vanhove; M Verstraete
Journal:  Am J Cardiol       Date:  1991-07-15       Impact factor: 2.778

10.  Effectiveness of double bolus alteplase in the treatment of acute myocardial infarction.

Authors:  J A Purvis; T G Trouton; M J Roberts; P McKeown; M G Mulholland; G W Dalzell; C M Wilson; G C Patterson; S W Webb; M M Khan
Journal:  Am J Cardiol       Date:  1991-12-15       Impact factor: 2.778
View more
  1 in total

1.  Current Clinical Experience with Staphylokinase in Arterial Thrombosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.